Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
CareDx, Inc. is a leading company specializing in diagnostic solutions for transplant patients. Their main products include AlloSure and AlloMap tests for monitoring organ transplant health, alongside HLA typing and patient management software. CareDx aims to improve transplant outcomes through advanced diagnostics and digital health tools.
AI-generated summary. Not investment advice.